Stanker James H Insider Trades

Insider Trading History

Track insider trading activity for Stanker James H. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $18.6k 6,764 shares
Last Trade
Jul 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.5k 644 shares
$42.75
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $17.8k 6,482 shares
Last Trade
Jul 10, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$12.1k 282 shares
$42.75
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $81.3k 29,547 shares
Last Trade
Jun 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$345k 6,154 shares
$56.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $18.3k 6,638 shares
Last Trade
Apr 05, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$117k 1,675 shares
$69.75
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $16.8k 6,120 shares
Last Trade
Apr 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$36.1k 518 shares
$69.75
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $16.8k 6,120 shares
Last Trade
Jan 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.47k 518 shares
$6.69
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $66.1k 24,037 shares
Last Trade
Jan 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.2k 1,675 shares
$6.69
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $18.3k 6,638 shares
Last Trade
Jan 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.2k 1,675 shares
$6.69
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $273k 99,250 shares
Last Trade
Oct 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99k 15,000 shares
$6.60
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $232k 84,250 shares
Last Trade
Oct 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90.9k 22,500 shares
$4.04
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $170k 61,750 shares
Last Trade
Feb 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 12,500 shares
$400.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $1.43M 518,431 shares
Last Trade
Jan 01, 2023 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.2M 165,817 shares
$550.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $970k 352,614 shares
Last Trade
Dec 31, 2022 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.12M 12,951 shares
$550.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $898k 326,713 shares
Last Trade
Sep 30, 2022 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.1M 23,947 shares
$1,130.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $934k 339,663 shares
Last Trade
Sep 30, 2022 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.6M 12,950 shares
$1,130.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $135k 49,250 shares
Last Trade
Aug 05, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.9M 2,462 shares
$1,585.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $142k 51,712 shares
Last Trade
Aug 05, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12M 7,601 shares
$1,585.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $898k 326,713 shares
Last Trade
Jun 30, 2022 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.6M 23,947 shares
$1,405.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $833k 302,766 shares
Last Trade
Apr 01, 2022 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$384M 247,841 shares
$1,550.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Financial Officer
Holding Value $104k 37,781 shares
Last Trade
Mar 31, 2022 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.1M 10,715 shares
$1,505.00
$2.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up